|
In
order to fulfill the 45-credit hour
requirement, trainees may complete one of
four optional Focus Areas:
-
Clinical Epidemiology/Clinical
Effectiveness
-
Molecular Epidemiology
-
Clinical Trials
-
Translational Research
|
Clinical
Epidemiology and Clinical Effectiveness |
| Directed
by Joel Tsevat, MD, MPH, PI; and Maria Britto, MD, MPH |
|
Using a combination of
didactic material and seminars, the Clinical
Epidemiology/Clinical Effectiveness Focus
Area enables participants to develop the
analytic and quantitative skills necessary
to conduct clinical research. The required
courses will provide training in traditional
epidemiologic research methods including
study design and analysis. Additional
courses will address the relative merits of
various designs; the design and conduct of
clinical trials; the health decision
sciences; health services research;
informatics; questionnaire development; and
other clinical and outcomes research topics.
Didactic sessions will be supplemented by
small discussion groups, practical
exercises, and invited guest speakers.
|
Required courses
|
Course Number |
Course Title |
Credit hours |
Quarter |
|
26-BE-766 |
Design and Analysis of Clinical
Trials |
3 |
Autumn |
|
26-BE-788 |
Regression Analysis |
4 |
Winter |
|
26-BE-867 |
*Health
Services Research |
3 |
Spring |
|
26-BE-862 |
*Introduction
to Biomedical Informatics |
3 |
Winter |
|
26-BE-768 |
*Decision
Analysis and Cost-Effectiveness
Analysis |
3 |
Winter |
|
26-BE-770 |
*Survey
and Qualitative Methods in Health
Research |
2 |
Spring |
|
26-BE-769 |
*Quality
Improvement and Patient Safety |
3 |
Autumn |
*Should take
3 of the listed 5 selective courses.
|
Molecular Epidemiology |
|
Directed by Grace LeMasters, PhD
|
We define molecular
epidemiology as the use of biological
markers in epidemiologic research to
evaluate events occurring at the
physiologic, cellular, subcellular, and
molecular levels. The Molecular Epidemiology
Focus Area encompasses biomarker, cancer,
and genetic epidemiology. The overall
objective of the Molecular Epidemiology
Focus Area is to establish an
interdisciplinary training program in
molecular epidemiology for clinicians
seeking an advanced degree (MS or PhD). With
the requisite didactic coursework,
laboratory experience, and mentoring,
students will develop the knowledge base and
conceptual framework of scientific inquiry
to foster independent research careers in
molecular epidemiology. The Molecular
Epidemiology Focus Area builds on research,
teaching, and mentoring strength within the
Center for Environmental Genetics and the
Center for Genome Research, comprised of
interdisciplinary investigators of
world-class scientists in the Department of
Environmental Health.|
|
Required courses
|
Course
Number |
Course Title |
Credit hours |
Quarter |
|
26-BE-866 |
Molecular Epidemiology Laboratory |
1 |
Spring |
|
26-BE-868 |
Genetics of Complex Diseases |
3 |
Autumn (even years) |
|
26-GNTD-871 |
Introduction to Molecular Genetics |
4 |
Autumn |
|
26-CB-880
35-GC-881 |
Biology of Cancer
or
Human Genetics I |
3
3 |
Spring
Spring |
|
26-BE-763 |
Pediatric Environmental Health |
3 |
Spring (even years) |
|
26-BE-764 |
Statistical Genetics I |
3 |
Winter (odd years) |
|
Independent Study |
Molecular Epidemiology Lab Rotation
Independent Study
(3 quarters required) |
Varied |
Autumn, Winter, and
Spring |
|
Clinical Trials |
|
Directed by Pankaj Desai, PhD |
|
The overall objective of the
Clinical Trials Focus Area is to train
clinical researchers interested in clinical
trials and translational research. Trainees
concentrating in Clinical Trials will learn
the fundamentals of clinical trials and the
drug/device development process, including
the responsible conduct of research, the
phases of clinical trials, and regulatory
affairs. A unique aspect of the curriculum
is that UC professors team with industry
leaders to teach several of the courses, so
that students get a “real world” experience.
The electives for this Focus Area are taught
through the College of Pharmacy.
These trainees gain the skills required to
effectively complete investigator-initiated,
IND-directed early phase clinical trials.
Trainees learn critical aspects of study
design and conduct, mechanisms of financial
support, and data analysis and publication.
A basic understanding of laboratory methods,
data analysis, and the molecular basis of
disease is critical to bridge laboratory and
clinical research and is therefore included
in the training. The curriculum covers
training in pre-clinical efficacy and
toxicology studies that are required to
support early phase clinical trials. In
addition, regulatory affairs issues unique
to translational research are covered.
|
Required courses
|
Course Number |
Course Title |
Credit hours |
Quarter |
|
26-BE-766 |
Design and Analysis of Clinical
Trials |
3 |
Autumn |
|
25-PHDD-601 |
Global Drug Development |
3 |
Autumn |
|
25-PHDD-701 |
Clinical Trials Design and Research
II |
3 |
Autumn |
|
25-PHDD-703 |
Clinical Trials Design and Research
III |
3 |
Winter |
|
25-PHDD-606 |
Regulatory Affairs II |
3 |
Spring |
|
Translational Research
|
|
Directed by Timothy Cripe, PhD, MD
|
|
Translational research is
broadly defined as research that will
provide a scientific link between laboratory
research and human clinical practice. This
area includes preclinical and early phase
clinical testing of new therapeutic or
diagnostic reagents, as well as collection
and handling of patient specimens. Students
will take courses in the College of Pharmacy
geared towards clinical trials and
regulatory affairs and in Developmental
Biology, Disease and Development. Two new
courses have been created for this focus
area: Patient Specimen Methods and Disease
Specific Translational Research. To gain a
more solid understanding of the molecular
mechanisms underlying diseases, trainees may
fill the elective hours with the molecular
biology series offered at UC each year.
Ideally, research projects will encompass
late preclinical or early clinical projects.
|
Required courses
|
Course Number |
Course Title |
Credit hours |
Quarter |
|
25-PHDD-605 |
Clinical Trials Design and Research
I |
3 |
Spring |
|
25-PHDD-602 |
Regulatory Affairs I: Pre-Clinical/IND |
3 |
Autumn |
|
26-DB-987 |
Disease and Development |
3 |
Autumn (even years) |
|
26-BE-TBA |
Patient Specimen Methods |
1 |
TBA |
|
26-BE-TBA |
Disease Specific Translational
Research |
1 |
TBA |
MSCRTP Alumni? Join UC
inCircle to stay inTouch with colleagues,
friends and faculty!

|